109 related articles for article (PubMed ID: 31794190)
1. Phenotypic Screen Identifies JAK2 as a Major Regulator of FAT10 Expression.
Reznik N; Kozer N; Eisenberg-Lerner A; Barr H; Merbl Y; London N
ACS Chem Biol; 2019 Dec; 14(12):2538-2545. PubMed ID: 31794190
[TBL] [Abstract][Full Text] [Related]
2. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Interferon Induction by the Ubiquitin-Like Modifier FAT10.
Mah MM; Roverato N; Groettrup M
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586037
[TBL] [Abstract][Full Text] [Related]
4. Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10.
Spinnenhirn V; Bitzer A; Aichem A; Groettrup M
FEBS Lett; 2017 Jan; 591(1):186-195. PubMed ID: 27926780
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platform.
Nguyen NT; Now H; Kim WJ; Kim N; Yoo JY
Sci Rep; 2016 Mar; 6():23377. PubMed ID: 26996158
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-like modifier FAT10 in cancer development.
Aichem A; Groettrup M
Int J Biochem Cell Biol; 2016 Oct; 79():451-461. PubMed ID: 27393295
[TBL] [Abstract][Full Text] [Related]
7. FAT10 stimulates the development of osteosarcoma by regulating the JAK/STAT signaling pathway.
Shi F; Li L; Cheng Y
J BUON; 2021; 26(5):2090-2096. PubMed ID: 34761621
[TBL] [Abstract][Full Text] [Related]
8. FAT10 suppression stabilizes oxidized proteins in liver cells: Effects of HCV and ethanol.
Ganesan M; Hindman J; Tillman B; Jaramillo L; Poluektova LI; French BA; Kharbanda KK; French SW; Osna NA
Exp Mol Pathol; 2015 Dec; 99(3):506-16. PubMed ID: 26407761
[TBL] [Abstract][Full Text] [Related]
9. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
[TBL] [Abstract][Full Text] [Related]
10. FAT10ylation as a signal for proteasomal degradation.
Schmidtke G; Aichem A; Groettrup M
Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
[TBL] [Abstract][Full Text] [Related]
11. FAT10, a ubiquitin-independent signal for proteasomal degradation.
Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
[TBL] [Abstract][Full Text] [Related]
12. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.
Schmidtke G; Kalveram B; Groettrup M
FEBS Lett; 2009 Feb; 583(3):591-4. PubMed ID: 19166848
[TBL] [Abstract][Full Text] [Related]
13. The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway.
Bett JS; Kanuga N; Richet E; Schmidtke G; Groettrup M; Cheetham ME; van der Spuy J
PLoS One; 2012; 7(2):e30866. PubMed ID: 22347407
[TBL] [Abstract][Full Text] [Related]
14. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
[TBL] [Abstract][Full Text] [Related]
15. The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functions.
Schregle R; Mah MM; Mueller S; Aichem A; Basler M; Groettrup M
Immunogenetics; 2018 Jul; 70(7):429-438. PubMed ID: 29508036
[TBL] [Abstract][Full Text] [Related]
16. FAT10 attenuates hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3.
Zhou Q; Peng X; Liu X; Chen L; Xiong Q; Shen Y; Xie J; Xu Z; Huang L; Hu J; Wan R; Hong K
J Mol Cell Cardiol; 2018 Mar; 116():115-124. PubMed ID: 29438664
[TBL] [Abstract][Full Text] [Related]
17. FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.
Gao Y; Theng SS; Zhuo J; Teo WB; Ren J; Lee CG
Carcinogenesis; 2014 Apr; 35(4):923-34. PubMed ID: 24325913
[TBL] [Abstract][Full Text] [Related]
18. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
Aichem A; Catone N; Groettrup M
FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
[TBL] [Abstract][Full Text] [Related]
19. FAT10 promotes the invasion and migration of breast cancer cell through stabilization of ZEB2.
Zou Y; Ouyang Q; Wei W; Yang S; Zhang Y; Yang W
Biochem Biophys Res Commun; 2018 Nov; 506(3):563-570. PubMed ID: 30361097
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.
Kalveram B; Schmidtke G; Groettrup M
J Cell Sci; 2008 Dec; 121(Pt 24):4079-88. PubMed ID: 19033385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
